Filtros de búsqueda

Lista de obras de Florian Handle

AR variants: lost in translation to clinical practice?

scientific article published on 01 August 2019

Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide.

artículo científico publicado en 2016

Drivers of AR indifferent anti-androgen resistance in prostate cancer cells

artículo científico publicado en 2019

Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy

artículo científico publicado en 2017

Fractionated Radiation of Primary Prostate Basal Cells Results in Downplay of Interferon Stem Cell and Cell Cycle Checkpoint Signatures

artículo científico publicado en 2018

IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9 ⬇️

artículo científico publicado el 23 de agosto de 2013

Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits

artículo científico publicado en 2012

Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

artículo científico publicado en 2015

On the use of frequency-domain reconstruction algorithms for photoacoustic imaging ⬇️

artículo científico publicado el 1 de agosto de 2011

PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer.

artículo científico publicado en 2015

SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells.

artículo científico publicado en 2016

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse

artículo científico publicado en 2021

The AR/NCOA1 axis regulates prostate cancer migration by involvement of PRKD1.

artículo científico publicado en 2016

The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy.

artículo científico publicado en 2017

The STAT3 inhibitor galiellalactone reduces IL6-mediated AR activity in benign and malignant prostate models

artículo científico publicado en 2018

The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling.

artículo científico publicado en 2017

The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells

scientific article published on 13 December 2019

p300 is up-regulated by docetaxel and is a target in chemoresistant prostate cancer

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda